BlackRock Unconstrained Equity Fund
MDEGX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Anne Frances Ackerley
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Plainoboro, NJ 08536 Plainoboro NJ United States of America 08536
- IPO Date
- Nov 4, 2005
- CIK
- 0001324285
- Website
- blackrock.com
- Similar Companies
- Business
- BlackRock Unconstrained Equity Fund (MDEGX) is an open-end mutual fund that seeks long-term capital growth through an unconstrained equity investment approach, investing primarily in global large-cap growth stocks across sectors, market capitalizations, countries, and styles without benchmark constraints; it employs fundamental research to select high-quality companies with resilient earnings and long-term compounding potential via free cash flows. The fund offers multiple share classes including Investor A Shares (MDEGX, net expense ratio 1.16%), Institutional Shares (MAEGX, net expense ratio 0.95%), Investor C Shares (MCEGX), Class R Shares (MREGX), and Class K Shares (MKEAX), with a concentrated portfolio typically comprising 20-30 holdings such as Microsoft Corp., Meta Platforms Inc., Amazon.com Inc., Cadence Design Systems Inc., Visa Inc., Mastercard Inc., and international names like ASML Holding NV and Trane Technologies PLC; geographic allocation emphasizes the United States (approximately 78%), with additional exposure to the Netherlands, France, Italy, and the United Kingdom. Managed by BlackRock Advisors, LLC at 100 Bellevue Parkway, Wilmington, DE 19809, with oversight from 50 Hudson Yards, New York, NY, the fund was launched on November 4, 2005, as part of BlackRock's equity strategies targeting institutional and retail investors in the global large-stock growth category. In a significant strategic shift on March 1, 2022, the fund transitioned from its prior identity as BlackRock Long-Horizon Equity Fund, adopting a new unconstrained investment objective, strategies, and process under lead managers Alister Hibbert and Michael Constantis to enhance flexibility and performance potential; recent portfolio adjustments included selling the position in Novo Nordisk A/S following weaker-than-expected weight-loss drug trial data in late 2024, while top contributors like Intuitive Surgical Inc. and Masimo Corp. benefited from strong demand and governance resolutions during the fiscal year ended April 30, 2025, amid a portfolio turnover rate of 62% and net assets of approximately $1.29 billion.